Brief: Suven Pharmaceuticals To Buy Casper Pharma For $20.5 Mln
April 5 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* TO BUY ENTIRE SHARE CAPITAL FROM EXISTING SHAREHOLDERS OF
CASPER
PHARMA
* DEAL FOR $20.5 MILLION
Source text for Eikon: ID:nBSE8V9GtF
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss